Vaxcyte OverviewVaxcyte EBIT
EBIT (Earnings Before Interest and Taxes) analysis for PCVX.
Quarterly EBIT
-$345.85M
↓ 91.3% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$1.00B
↓ 86.96% YoY
Trailing 12 months ending Mar 31, 2026
Vaxcyte OverviewEBIT (Earnings Before Interest and Taxes) analysis for PCVX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026